Adherence to antiparkinsonian medication: an in-depth qualitative study

International Journal of Nursing Studies
Nick DreyDinah Gould

Abstract

Adherence to prescribed medication is low. It is a major problem as following practitioners' recommendations is strongly associated with good patient outcomes. Little research has been undertaken with people in the early stages of Parkinson's disease although achieving symptom control depends on regularly timing doses. How do people with Parkinson's disease adhere to prescribed medication, and what are the antecedents of non-adherence to antiparkinsonian medication? Exploratory qualitative study using semi-structured interviews. Specialist Parkinson's disease clinic in one National Health Service hospital in England. Fifteen consecutive patients not yet in the advanced stages of Parkinson's disease living at home and responsible for managing their own medication or managing medication with the help of their carer. Semi-structured interviews with open questions. Each respondent demonstrated at least one type and in most cases several different types of non-adherent behaviour. Inadvertent minor non-adherence occurred because patients forgot to take tablets or muddled doses. Minor deliberate deviations occurred when patients took occasional extra tablets or brought forward doses to achieve better symptom control, often to cater fo...Continue Reading

References

Apr 13, 2000·International Journal of Nursing Studies·H ReynoldsG Richardson
Jun 22, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A Chesney
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Steven Frucht
Jul 11, 2002·Clinical Medicine : Journal of the Royal College of Physicians of London·Robert L Tattersall
Apr 1, 2003·Annals of Neurology·Olivier RascolJean-Louis Montastruc
Aug 26, 2004·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Jasmina BajramovicSusan E Tett
Jan 20, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·K A GrossetD Grosset
Feb 16, 2006·Archives of Neurology·Cathy LuOksana Suchowersky
Nov 11, 2006·Clinical Neuropharmacology·Robert A HauserGregor K Wenning
Mar 24, 2007·British Journal of Clinical Pharmacology·Jeffrey K Aronson
Nov 28, 2007·Nursing Standard·Kevin J Frost
Mar 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Mariese A HelyJohn G L Morris
Feb 5, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Donald GrossetKatherine Grosset
Sep 12, 2009·Nursing Standard·Gerri Kaufman, Yvonne Birks

❮ Previous
Next ❯

Citations

Sep 21, 2013·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Tapani Keränen, Sammeli Liikkanen
Dec 20, 2014·TheScientificWorldJournal·Andrew SoundyCarolyn Roskell
Dec 20, 2014·Parkinsonism & Related Disorders·Elan D Louis
Mar 3, 2015·Geriatric Nursing·Ju Young ShinIngrid Pretzer-Aboff
May 26, 2016·The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses·Ju Young Shin, Barbara Habermann
Jul 4, 2015·British Journal of Community Nursing·Krupa Patel
Jan 28, 2020·Age and Ageing·Matthew RoycroftJoanne Rose
Aug 11, 2020·Movement Disorders Clinical Practice·Michelle H S TosinBeatriz Guitton R B Oliveira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the Neurological Sciences
Donald Grosset, European PD Therapy Compliance Study Group
Parkinsonism & Related Disorders
Mary G Baker
© 2022 Meta ULC. All rights reserved